Enteral Nutrition Market Report 2026

The enteral nutrition market size has grown strongly in recent years. It will grow from $13.31 billion in 2025 to $14.34 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing hospitalization rates, growth of critical care nutrition usage, expansion of clinical nutrition awareness, availability of standardized enteral formulas.

The enteral nutrition market size is expected to see strong growth in the next few years. It will grow to $20.08 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing aging population, rising demand for home healthcare nutrition, expansion of personalized medical nutrition, increasing focus on long-term disease management, innovation in specialized enteral formulations. Major trends in the forecast period include increasing adoption of disease-specific enteral formulations, rising demand for high-protein and specialized nutrition, expansion of home-based enteral feeding solutions, growing focus on pediatric and geriatric nutrition, product innovation in fiber and amino acid blends.

The rising prevalence of chronic diseases is expected to drive demand for enteral nutrition. Chronic or non-communicable diseases (NCDs) are long-term conditions that generally progress slowly and persist over an extended period. These include cardiovascular diseases, diabetes, respiratory disorders, cancer, chronic kidney disease, neurological conditions, rheumatoid arthritis, and other autoimmune diseases. Enteral nutrition serves as a supportive solution for patients who experience difficulty eating or maintaining sufficient nutrition due to their illness or related treatments. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 35 million new cancer cases are projected by 2050, representing a 77% increase compared to the estimated 20 million cases reported in 2022. Therefore, the growing prevalence of chronic diseases is driving the enteral nutrition market.

Major companies operating in the enteral nutrition market are concentrating on the development of next-generation enteral feeding systems, such as advanced enteral feeding pumps, to reinforce their market position. The Kangaroo OMNI Enteral Feeding Pump is a next-generation system designed to deliver nutrition and hydration seamlessly from hospital settings to home care environments. For example, in September 2023, Cardinal Health Inc., a US-based healthcare company, introduced the Kangaroo OMNI enteral feeding pump. The system is designed to address the enteral feeding needs of both patients and caregivers, offering the lightest, smallest, and quietest Kangaroo feed and flush enteral feeding pump while supporting a broader range of commercially available enteral formulas.

In April 2023, Danone, a France-based food group, acquired Promedica for an undisclosed amount. This acquisition aligns with Danone’s strategic revitalization plan, which focuses on investing in high-value brands and innovation while divesting underperforming assets. Promedica is a Poland-based company that specializes in providing home care services for patients.

Major companies operating in the enteral nutrition market are Cardinal Health Inc., Nestle S.A., Fresenius Kabi AG, Abbott Laboratories, Medtronic Inc., Danone S.A., Becton, Dickinson and Company, Otsuka Pharmaceutical Factory, Boston Scientific Corporation, Hormel Foods Corporation, B. Braun Melsungen AG, Reckitt Benckiser Group PLC, Meiji Holdings Co. Ltd., C. R. Bard GmbH, Moog Inc., Mead Johnson Nutrition, Cook Medical, Halyard Health Inc., Avanos Medical Inc., Applied Medical, Angiplast Pvt Ltd., Kate Farms, Global Health Products Inc., Victus Inc., VYGON SAS.

North America was the largest region in the enteral nutrition market in 2025. The regions covered in the enteral nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the enteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The enteral nutrition market includes revenues earned by providing nutrients, fats and other component through the feeding tube, management of malnutrition, dietary management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.